These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

318 related items for PubMed ID: 18408246

  • 1. Bone mineral density in rheumatoid arthritis patients 1 year after adalimumab therapy: arrest of bone loss.
    Wijbrandts CA, Klaasen R, Dijkgraaf MG, Gerlag DM, van Eck-Smit BL, Tak PP.
    Ann Rheum Dis; 2009 Mar; 68(3):373-6. PubMed ID: 18408246
    [Abstract] [Full Text] [Related]

  • 2. Effects of low dose methotrexate on the bone mineral density of patients with rheumatoid arthritis.
    Buckley LM, Leib ES, Cartularo KS, Vacek PM, Cooper SM.
    J Rheumatol; 1997 Aug; 24(8):1489-94. PubMed ID: 9263140
    [Abstract] [Full Text] [Related]

  • 3. Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?
    van der Goes MC, Jacobs JW, Jurgens MS, Bakker MF, van der Veen MJ, van der Werf JH, Welsing PM, Bijlsma JW.
    Osteoporos Int; 2013 Apr; 24(4):1429-36. PubMed ID: 23011680
    [Abstract] [Full Text] [Related]

  • 4. The effect of tocilizumab on bone mineral density in patients with methotrexate-resistant active rheumatoid arthritis.
    Kume K, Amano K, Yamada S, Kanazawa T, Ohta H, Hatta K, Amano K, Kuwaba N.
    Rheumatology (Oxford); 2014 May; 53(5):900-3. PubMed ID: 24441151
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Tocilizumab potentially prevents bone loss in patients with anticitrullinated protein antibody-positive rheumatoid arthritis.
    Chen YM, Chen HH, Huang WN, Liao TL, Chen JP, Chao WC, Lin CT, Hung WT, Hsieh CW, Hsieh TY, Chen YH, Chen DY.
    PLoS One; 2017 May; 12(11):e0188454. PubMed ID: 29155868
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Are there any positive effects of TNF-alpha blockers on bone metabolism?].
    Seriolo B, Paolino S, Sulli A, Cutolo M.
    Reumatismo; 2006 May; 58(3):199-205. PubMed ID: 17013436
    [Abstract] [Full Text] [Related]

  • 9. Tumour necrosis factor blockade and the risk of osteoporosis: back to the future.
    Sambrook P.
    Arthritis Res Ther; 2007 May; 9(4):107. PubMed ID: 17850677
    [Abstract] [Full Text] [Related]

  • 10. Evaluation of bone mineral density, bone metabolism, osteoprotegerin and receptor activator of the NFkappaB ligand serum levels during treatment with infliximab in patients with rheumatoid arthritis.
    Vis M, Havaardsholm EA, Haugeberg G, Uhlig T, Voskuyl AE, van de Stadt RJ, Dijkmans BA, Woolf AD, Kvien TK, Lems WF.
    Ann Rheum Dis; 2006 Nov; 65(11):1495-9. PubMed ID: 16606653
    [Abstract] [Full Text] [Related]

  • 11. Abatacept might increase bone mineral density at femoral neck for patients with rheumatoid arthritis in clinical practice: AIRTIGHT study.
    Tada M, Inui K, Sugioka Y, Mamoto K, Okano T, Koike T.
    Rheumatol Int; 2018 May; 38(5):777-784. PubMed ID: 29294175
    [Abstract] [Full Text] [Related]

  • 12. The change of bone mineral density according to treatment agents in patients with ankylosing spondylitis.
    Kang KY, Lee KY, Kwok SK, Ju JH, Park KS, Hong YS, Kim HY, Park SH.
    Joint Bone Spine; 2011 Mar; 78(2):188-93. PubMed ID: 20621536
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Changes in bone mineral density during long-term treatment with adalimumab in patients with rheumatoid arthritis: a cohort study.
    Krieckaert CL, Nurmohamed MT, Wolbink G, Lems WF.
    Rheumatology (Oxford); 2013 Mar; 52(3):547-53. PubMed ID: 23221326
    [Abstract] [Full Text] [Related]

  • 17. Bone mineral density in patients with rheumatoid arthritis: relation between disease severity and low bone mineral density.
    Lodder MC, de Jong Z, Kostense PJ, Molenaar ET, Staal K, Voskuyl AE, Hazes JM, Dijkmans BA, Lems WF.
    Ann Rheum Dis; 2004 Dec; 63(12):1576-80. PubMed ID: 15547081
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Effect of cyclosporine A on bone density in female rheumatoid arthritis patients: results from a multicenter, cross-sectional study.
    Mazzantini M, Di Munno O, Sinigaglia L, Bianchi G, Rossini M, Mela Q, Del Puente A, Frediani B, Cantatore F, Adami S.
    Clin Exp Rheumatol; 2007 Dec; 25(5):709-15. PubMed ID: 18078618
    [Abstract] [Full Text] [Related]

  • 20. Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis.
    Güler-Yüksel M, Bijsterbosch J, Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Hulsmans HM, de Beus WM, Han KH, Breedveld FC, Dijkmans BA, Allaart CF, Lems WF.
    Ann Rheum Dis; 2008 Jun; 67(6):823-8. PubMed ID: 17644545
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.